CGNX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cognex Corp (CGNX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows positive financial performance and has received favorable analyst ratings, the recent negative price movement, lack of strong proprietary trading signals, and insider selling activity suggest caution. For now, holding the stock or waiting for a better entry point may be more prudent.
The stock's MACD is negatively expanding (-0.318), RSI is neutral at 39.813, and moving averages are converging, indicating no strong trend. Key support is at 48.251, resistance at 51.521. The stock closed at $50.07, slightly above support but with bearish momentum.
Hedge funds are significantly increasing their buying activity (+2450.31%). Analysts have raised price targets, with some projecting up to $75, citing margin improvements, cost initiatives, and a strengthening macroeconomic backdrop.
Insiders are heavily selling shares (+4627.11%), which may indicate a lack of confidence. The stock has experienced a sharp decline in regular market trading (-4.42%) and pre-market (-2.33%). No recent news or event-driven catalysts to support a rebound.
In Q4 2025, revenue increased 9.86% YoY to $252.3M, net income rose 15.23% YoY to $32.66M, and EPS grew 18.75% YoY to $0.19. However, gross margin dropped to 65.75%, down 4.34% YoY, which could signal cost pressures.
Analysts are generally positive, with multiple upgrades and price target increases. Barclays, TD Cowen, and HSBC have raised targets, with some projecting up to $75. The consensus highlights margin improvements, cost initiatives, and sector recovery as key drivers.
